Literature DB >> 27083141

HI-6 assisted catalytic scavenging of VX by acetylcholinesterase choline binding site mutants.

Nikolina Maček Hrvat1, Suzana Žunec1, Palmer Taylor2, Zoran Radić2, Zrinka Kovarik3.   

Abstract

The high toxicity of organophosphorus compounds originates from covalent inhibition of acetylcholinesterase (AChE), an essential enzyme in cholinergic neurotransmission. Poisonings that lead to life-threatening toxic manifestations require immediate treatment that combines administration of anticholinergic drugs and an aldoxime as a reactivator of AChE. An alternative approach to reduce the in vivo toxicity of OPs focuses on the use of bioscavengers against the parent organophosphate. Our previous research showed that AChE mutagenesis can enable aldoximes to substantially accelerate the reactivation of OP-enzyme conjugates, while dramatically slowing down rates of OP-conjugate dealkylation (aging). Herein, we demonstrate an efficient HI-6-assisted VX detoxification, both ex vivo in human blood and in vivo in mice by hAChE mutants modified at the choline binding site (Y337A and Y337A/F338A). The catalytic scavenging of VX in mice improved therapeutic outcomes preventing lethality and resulted in a delayed onset of toxicity symptoms. Copyright Â
© 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  2-PAM; Antidotes; Cholinesterase; Nerve agents; Organophosphates; Oximes; Reactivation

Mesh:

Substances:

Year:  2016        PMID: 27083141      PMCID: PMC5061595          DOI: 10.1016/j.cbi.2016.04.023

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  33 in total

1.  The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase.

Authors:  L Raveh; E Grauer; J Grunwald; E Cohen; Y Ashani
Journal:  Toxicol Appl Pharmacol       Date:  1997-07       Impact factor: 4.219

2.  Catalytic Soman Scavenging by the Y337A/F338A Acetylcholinesterase Mutant Assisted with Novel Site-Directed Aldoximes.

Authors:  Zrinka Kovarik; Nikolina Maček Hrvat; Maja Katalinić; Rakesh K Sit; Alexander Paradyse; Suzana Žunec; Kamil Musilek; Valery V Fokin; Palmer Taylor; Zoran Radić
Journal:  Chem Res Toxicol       Date:  2015-04-16       Impact factor: 3.739

3.  In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.

Authors:  Maja Calić; Ana Lucić Vrdoljak; Bozica Radić; Dubravko Jelić; Daniel Jun; Kamil Kuca; Zrinka Kovarik
Journal:  Toxicology       Date:  2005-12-05       Impact factor: 4.221

4.  In vitro and in vivo characterization of recombinant human butyrylcholinesterase (Protexia) as a potential nerve agent bioscavenger.

Authors:  D M Cerasoli; E M Griffiths; B P Doctor; A Saxena; J M Fedorko; N H Greig; Q S Yu; Y Huang; H Wilgus; C N Karatzas; I Koplovitz; D E Lenz
Journal:  Chem Biol Interact       Date:  2005-12-15       Impact factor: 5.192

5.  Prophylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX.

Authors:  Ashima Saxena; Wei Sun; James M Fedorko; Irwin Koplovitz; Bhupendra P Doctor
Journal:  Biochem Pharmacol       Date:  2010-09-21       Impact factor: 5.858

Review 6.  Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning.

Authors:  Daniel Rochu; Eric Chabrière; Patrick Masson
Journal:  Toxicology       Date:  2006-09-03       Impact factor: 4.221

7.  Butyrylcholinesterase as a therapeutic drug for protection against percutaneous VX.

Authors:  David E Lenz; Edward D Clarkson; Susan M Schulz; Douglas M Cerasoli
Journal:  Chem Biol Interact       Date:  2010-06-01       Impact factor: 5.192

8.  Integrative analytical approach by capillary electrophoresis and kinetics under high pressure optimized for deciphering intrinsic and extrinsic cofactors that modulate activity and stability of human paraoxonase (PON1).

Authors:  Frédérique Renault; Tiffany Carus; Cécile Cléry-Barraud; Mikael Elias; Eric Chabrière; Patrick Masson; Daniel Rochu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-11-27       Impact factor: 3.205

Review 9.  Review of oximes available for treatment of nerve agent poisoning.

Authors:  R M Dawson
Journal:  J Appl Toxicol       Date:  1994 Sep-Oct       Impact factor: 3.446

10.  Catalytic bioscavengers against toxic esters, an alternative approach for prophylaxis and treatments of poisonings.

Authors:  Patrick Masson; Daniel Rochu
Journal:  Acta Naturae       Date:  2009-04       Impact factor: 1.845

View more
  1 in total

Review 1.  Counteracting poisoning with chemical warfare nerve agents.

Authors:  Nikolina Maček Hrvat; Zrinka Kovarik
Journal:  Arh Hig Rada Toksikol       Date:  2020-12-31       Impact factor: 2.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.